Biologic features and treatment outcome of secondary acute lymphoblastic leukemia - A review of 101 cases

Annals of Oncology

Volumn 19, Issue 9, 2008, Pages 1634-1638

  Shivakumar, R ^a   Tan, W ^b   Wilding, G E ^b   Wang, E S ^a,c   Wetzler, Meir ^a  

^a ROSWELL PARK CANCER INSTITUTE   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

^c UNIVERSITY AT BUFFALO   (United States)

Author keywords

11q23 aberrations; Acute lymphoblastic leukemia; Secondary neoplasms

Indexed keywords

ANTHRACYCLINE; ETOPOSIDE; GYRASE INHIBITOR;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADULT; AGE DISTRIBUTION; ALLOGENEIC STEM CELL TRANSPLANTATION; BREAST CANCER; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURGERY; CANCER SURVIVAL; CHROMOSOME 11Q23 ABERRATION; CHROMOSOME ABERRATION; CLINICAL ARTICLE; COMBINATION CHEMOTHERAPY; FEMALE; HODGKIN DISEASE; HUMAN; IMMUNOPHENOTYPING; KARYOTYPE; MALE; NEUROBLASTOMA; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE CANCER; REVIEW; SECOND CANCER; SECONDARY ACUTE LYMPHOBLASTIC LEUKEMIA; TREATMENT OUTCOME;

ADOLESCENT; ADULT; AGE FACTORS; ANALYSIS OF VARIANCE; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BIOPSY, NEEDLE; CAUSE OF DEATH; COHORT STUDIES; COMBINED MODALITY THERAPY; FEMALE; HODGKIN DISEASE; HUMANS; IMMUNOHISTOCHEMISTRY; KAPLAN-MEIERS ESTIMATE; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; PROGNOSIS; RISK FACTORS; SEX FACTORS; STATISTICS, NONPARAMETRIC; STEM CELL TRANSPLANTATION; SURVIVAL ANALYSIS; TREATMENT OUTCOME;

EID: 50849140142     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdn182     Document Type: Review

References (24)

1. Harris NL, Jaffe ES, Diebold J et al. World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee meeting-Airlie House, Virginia, November 1997. J Clin Oncol 1999; 17: 3835-3849.
2. Pagano L, Pulsoni A, Tosti ME et al. Acute lymphoblastic leukaemia occurring as second malignancy: Report of the GIMEMA archive of adult acute leukaemia. Gruppo Italiano Malattie Ematologiche Maligne dell'Adulto. Br J Haematol 1999; 106: 1037-1040.
3. Petit B, Mele L, Rack K et al. Characteristics of secondary acute lymphoblastic leukemia with L3 morphology in adult patients. Leuk Lymphoma 2002; 43: 1599-1604.
4. Boerma EG, van Imhoff GW, Appel IM et al. Gender and age-related differences in Burkitt lymphoma - epidemiological and clinical data from The Netherlands. Eur J Cancer 2004; 40: 2781-2787.
5. Stass S, Mirro J, Melvin S et al. Lineage switch in acute leukemia. Blood 1984; 64: 701-706.
6. Zuna J, Cave H, Eckert C et al. Childhood secondary ALL after ALL treatment. Leukemia 2007; 21: 1431-1435.
7. Leone G, Pagano L, Ben-Yehuda D, Voso MT. Therapy-related leukemia and myelodysplasia: Susceptibility and incidence. Haematologica 2007; 92: 1389-1398.
8. Pedersen-Bjergaard J, Philip P, Larsen SO et al. Therapy-related myelodysplasia and acute myeloid leukemia. Cytogenetc characteristics of 115 consecutive cases and risk in seven cohorts of patents treated intensively for malignant diseases in the Copenhagen series. Leukemia 1993; 7: 1975-1986.
9. Imamura J, Miyoshi I, Koeffler HP. p53 in hematologic malignancies. Blood 1994; 84: 2412-2421.
10. Koike M, Takeuchi S, Park S et al. Ovarian cancer: Loss of heterozygosity frequently occurs in the ATM gene, but structural alterations do not occur in this gene. Oncology 1999; 56: 160-163.
11. Sherif ZA, Danielsen M. Balanced t(11;15)(q23;q15) in a TP53+/+ breast cancer patient from a Li-Fraumeni syndrome family. Cancer Genet Cytogenet 2006; 168: 50-58.
12. Hartikainen JM, Tuhkanen H, Kataja V et al. An autosome-wide scan for linkage disequilibrium-based association in sporadic breast cancer cases in eastern Finland: Three candidate regions found. Cancer Epidemiol Biomarkers Prev 2005; 14: 75-80.
13. Nagahata T, Hirano A, Utada Y et al. Correlation of allelic losses and clinicopathological factors in 504 primary breast cancers, Breast Cancer 2002; 9: 208-215.
14. Carroll WL, Bhojwani D, Min DJ et al. Pediatric acute lymphoblastic leukemia. Hematology Am Soc Hematol Educ Program 2003; 102-131.
15. Wetzler M, Dodge RK, Mrozek K et al. Prospective karyotype analysis in adult acute lymphoblastic leukemia: The dancer and leukemia Group B experience. Blood 1999; 93: 3983-3993.
16. Schrappe M, Reiter A, Zimmermann M et al. Long-term results of four consecutive trials in childhood ALL performed by the ALL-BFM study group from 1981 to 1995. Berlin-Frankfurt-Munster. Leukemia 2000; 14: 2205-2222.
17. Larson RA. Management of acute lymphoblastic leukemia in older patients. Semin Hematol 2006; 43: 126-133.
18. Bhatia S, Sklar C. Second cancers in survivors of childhood cancer. Nat Rev Cancer 2002; 2: 124-132.
19. Liberzon E, Avigad S, Stark B et al. Germ-line ATM gene alterations are associated with susceptibility to sporadic T-cell acute lymphoblastic leukemia in children. Genes Chromosomes Cancer 2004; 39: 161-166.
20. Varady E, Deak B, Molnar ZS et al. Second malignancies after treatment for Hodgkin's disease. Leuk Lymphoma 2001; 42: 1275-1281.
21. Praga C, Bergh J, Bliss J et al. Risk of acute myeloid leukemia and myelodysplastic syndrome in trials of adjuvant epirubicin for early breast cancer: Correlation with doses of epirubicin and cyclophosphamide. J Clin Oncol 2005; 23: 4179-4191.
22. Smith SM, Le Beau MM, Huo D et al. Clinical-cytogenetic associations in 306 patients with therapy-related myelodysplasia and myeloid leukemia: the University of Chicago series. Blood 2003; 102: 43-52.
23. Moorman AV, Harrison CJ, Buck GA et al. Karyotype is an independent prognostic factor in adult acute lymphoblastic leukemia (ALL): Analysis of cytogenetic data from patients treated on the Medical Research Council (MRC) UKALLXII/Eastern Cooperative Oncology Group (ECOG) 2993 trial. Blood 2007; 109: 3189-3197.
24. Larson RA. Is secondary leukemia an independent poor prognostic factor in acute myeloid leukemia? Best Pract Res Clin Haematol 2007; 20: 29-37.